window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : March 11, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Medical Devices

  • Medical devices,Metabolic Diseases,Regulatory Affairs

    Medtronic expands Medicare access and FDA cleared options for MiniMed 780G diabetes system in the US

    Medtronic has announced a series of US regulatory and reimbursement [...]

    February 4, 2026
  • Infectious Diseases,Market Access & Commercialization,Medical devices

    Biocomposites launches SYNICEM spacers in Canada for joint revision surgery

    Biocomposites has launched its SYNICEM antibiotic-loaded preformed spacers in Canada, [...]

    January 30, 2026
  • Diagnostics,Infectious Diseases,Medical devices,Technology and platforms

    En Carta Diagnostics receives FDA breakthrough device designation for Lyme disease test

    En Carta Diagnostics has received FDA Breakthrough Device Designation for [...]

    January 30, 2026
  • Drug Delivery & Formulation,Healthcare leadership,Market Access & Commercialization,Medical devices,Movers & Shakers

    ViCentra appoints Reman McDonagh as vice president, global marketing to support Kaleido scale-up

    ViCentra has appointed Reman McDonagh as vice president, global marketing [...]

    January 29, 2026
  • CDMOs & Manufacturing,Drug Delivery & Formulation,Medical devices,Pharmaceuticals and therapeutics,Technology and platforms

    MGS launches A.i.r. platform delivering customizable auto-injector solutions

    MGS has launched the A.i.r. Platform, a new customizable auto-injector [...]

    January 19, 2026
  • Drug Delivery & Formulation,Events and Conferences,Manufacturing,Packaging,Sustainability

    Pharmapack 2026 to return to Paris with focus on GLP-1 therapies and sustainable packaging

    Pharmapack will return to Paris in January 2026, with this [...]

    January 8, 2026
  • Dermatology,Market Access & Commercialization,Medical devices,Partnerships & Funding

    Hyphens Pharma out-licenses Cerapro MED cream for six European markets

    Hyphens Pharma International Limited (Hyphens Pharma), a Singapore-based specialty pharmaceutical [...]

    January 5, 2026
  • Chronic diseases,Clinical studies,Medical devices

    Study highlights laser device that could delay knee replacement surgery

    A newly published study has introduced a minimally invasive laser [...]

    December 19, 2025
  • Clinical studies,Clinical Trials,Drug approval,Medical devices,Patient Centricity,Pharmaceuticals and therapeutics,Regulatory Affairs

    Amber Implants secures FDA clearance for VCFix spinal system

    Amber Implants has received FDA 510(k) clearance for its VCFix [...]

    September 22, 2025
  • Medical devices

    Morphic Medical appoints Jane Wright as chief financial officer during European rollout of Reset

    Appointment strengthens leadership team as company expands access to its [...]

    September 15, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • ViiV Healthcare reports 12-month data showing lotivibart maintains viral suppression in ultra long-acting HIV regimen
    Categories: Clinical Development, Infectious Diseases, Patient Centricity, Precision medicine
  • SPT Labtech and Illumina to develop automated platform for decentralised oncology genomics
    Categories: Diagnostics, Oncology, Partnerships & Funding
  • Young adults in US, UK and Australia hit hardest by global mental health decline
    Categories: Clinical studies, Digital Health, Global health, Mental health, Neurosciences
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top